Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Eli Lilly And Co (LLY)

2014-09-22@21:03:09 ET
Eli Lilly & Co.Corporate Event Announcement Notice (WSH)

2014-09-22@13:27:57 ET
Eli Lilly (LLY) Showing Bullish Technicals With Resistance At $67.43 (FBM)

2014-09-22@07:12:01 ET
Dyax Corp. Highlights Recent Progress in Licensing and Funded Research Portfolio (BIZ)

2014-09-22@01:54:06 ET
Denovo Biopharma Purchases Late-Stage Oncology Drug from Eli Lilly (CLM)

2014-09-19@15:59:02 ET
Eli Lilly: 52-Week High Recently Eclipsed (LLY) (F71)

2014-09-19@11:28:32 ET
Eli Lilly (LLY) Showing Bullish Technicals With Support At $65.81 (FBM)

2014-09-19@10:41:57 ET
Watch for Shares of Eli Lilly (LLY) to Approach Resistance at $67.05 (F79)

2014-09-19@08:15:00 ET
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent (PRN)

2014-09-19@07:43:17 ET
Eli Lilly and Company wins US FDA's approval for Trulicity for glycemic control in adults with type 2 diabetes (MTO)

2014-09-18@17:45:00 ET
FDA Approves Trulicity(TM) (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes (PRN)

2014-09-18@17:01:25 ET
Look for Shares of Eli Lilly to Potentially Pullback after Yesterday's 1.03% Rise (PSM)

2014-09-18@17:00:52 ET
SmarTrend Watching for Potential Pullback in Shares of Eli Lilly After 1.03% Gain (PSM)

2014-09-18@13:00:00 ET
The Gastric Cancer Market is Expected to More Than Triple Over the Next Ten Years, Capturing Nearly $3.8 million by 2023 (PRN)

2014-09-18@10:07:26 ET
AstraZeneca and Eli Lilly to develop and commercialize Alzheimer's disease drug (DTM)

2014-09-18@08:20:10 ET
Eli Lilly (LLY) Showing Bullish Technicals (FBM)

2014-09-18@08:00:24 ET
Elanco Animal Health, Dow AgroSciences Announce Strategic R&D Agreement (BIZ)

2014-09-18@08:00:00 ET
CYRAMZA(TM) In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line Gastric Cancer Patients (PRN)

2014-09-17@15:26:46 ET
Shares of Eli Lilly Have Risen Above Previous 52-Week High (F71)

2014-09-17@12:18:37 ET
Eli Lilly (LLY) Trading Near $64.53 Support Level (FBM)

2014-09-17@10:02:41 ET
Eli Lilly's Phase III metastatic colorectal cancer study meets primary endpoint (DTM)